Auga Group (AUG1L) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
22 Jan, 2026Executive summary
Revenue for H1 2024 was €34.67m, down 7% year-over-year, with unaudited results showing a decline due to lower sales and commodity prices.
Gross profit rose 92% to €3.45m and EBITDA increased 80% to €6.43m, reflecting improved operational efficiency despite lower sales.
Net loss narrowed to €6.87m from €9.14m in H1 2023, with net profit margin improving from -25% to -20%.
Operating costs decreased by 16% year-over-year, driven by efficiency and cost reduction programs.
EBITDA guidance for 2024 was revised downward, mainly due to underperformance in the crop growing segment.
Financial highlights
Operating costs fell by 16% compared to H1 2023, mainly from reduced marketing and salary expenses.
Cash and cash equivalents at period end were €1.1m, with total assets of €228.2m and equity of €55.2m.
Net cash from operating activities was €4.4m, while net cash used in investing and financing activities was €2.0m and €4.8m, respectively.
Total sales revenue in the dairy segment grew 7% year-over-year, with milk yields up 7% and cost per ton down 16%.
Mushroom segment prices rose 8%, offsetting inflation and salary increases.
Outlook and guidance
EBITDA guidance for 2024 was cut by 51%, primarily due to lower yields, higher production costs, and reduced subsidies in crop growing.
Dairy, mushroom, and FMCG segment EBITDA guidance remains unchanged and on track.
Crop segment outlook remains uncertain until full harvest results are available after Q3.
Biomethane market expected to recover, with positive gross margin anticipated in Q4.
The Group expects to receive a similar amount of agricultural subsidies in 2024 as in 2023.
Latest events from Auga Group
- EBITDA up 59%, gross profit rose, and tech advances drove improved Q1 2024 results.AUG1L
Q1 202431 Jan 2026 - Revenue fell 11% and net loss narrowed amid major restructuring and asset sales.AUG1L
Q2 202530 Sep 2025 - Restructuring, impairments, and market headwinds led to losses despite revenue growth.AUG1L
Q4 20241 Jul 2025